Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 163

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure

Open access
Gagat, Przemysław, Ostrówka, Michał, Duda-Madej, Anna, Mackiewicz, Paweł · 2024 · International Journal of Molecular Sciences

Abstract

Antimicrobial peptides (AMPs) are emerging as a promising alternative to traditional antibiotics due to their ability to disturb bacterial membranes and/or their intracellular processes, offering a potential solution to the growing problem of antimicrobial resistance. AMP effectiveness is governed by factors such as net charge, hydrophobicity, and the ability to form amphipathic secondary structures. When properly balanced, these characteristics enable AMPs to selectively target bacterial membranes while sparing eukaryotic cells. This review focuses on the roles of positive charge, hydrophobicity, and structure in influencing AMP activity and toxicity, and explores strategies to optimize them for enhanced therapeutic potential. We highlight the delicate balance between these properties and how various modifications, including amino acid substitutions, peptide tagging, or lipid conjugation, can either enhance or impair AMP performance. Notably, an increase in these parameters does not always yield the best results; sometimes, a slight reduction in charge, hydrophobicity, or structural stability improves the overall AMP therapeutic potential. Understanding these complex interactions is key to developing AMPs with greater antimicrobial activity and reduced toxicity, making them viable candidates in the fight against antibiotic-resistant bacteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms251910821

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 135

  1. Mendelsohn, 2002, “Like All That Lives”: Biology, Medicine and Bacteria in the Age of Pasteur and Koch, Hist. Philos. Life Sci., 24, 3, 10.1080/03919710210001714293 · DOI
  2. Aminov, R.I. (2010). A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future. Front. Microbiol., 1. · DOI · Paper page
  3. Durand, 2019, Antibiotic Discovery: History, Methods and Perspectives, Int. J. Antimicrob. Agents, 53, 371, 10.1016/j.ijantimicag.2018.11.010 · DOI · Paper page
  4. Uddin, 2021, Antibiotic Resistance in Microbes: History, Mechanisms, Therapeutic Strategies and Future Prospects, J. Infect. Public Health, 14, 1750, 10.1016/j.jiph.2021.10.020 · DOI · Paper page
  5. Blair, 2015, Molecular Mechanisms of Antibiotic Resistance, Nat. Rev. Microbiol., 13, 42, 10.1038/nrmicro3380 · DOI · Paper page
  6. MacGowan, 2017, Antibiotic Resistance, Medicine, 45, 622, 10.1016/j.mpmed.2017.07.006 · DOI · Paper page
  7. Rizvanov, 2019, World Health Organization Report: Current Crisis of Antibiotic Resistance, BioNanoScience, 9, 778, 10.1007/s12668-019-00658-4 · DOI · Paper page
  8. Kwon, 2021, The Post-Antibiotic Era Is Here, Science, 373, 471, 10.1126/science.abl5997 · doi:10.1126/science.abl5997
  9. Mancuso, G., Midiri, A., Gerace, E., and Biondo, C. (2021). Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens, 10. · DOI · Paper page
  10. Shomuyiwa, 2023, Top 10 Public Health Challenges to Track in 2023: Shifting Focus beyond a Global Pandemic, Public Health Chall., 2, e86, 10.1002/puh2.86 · DOI
  11. Chen, C.-Y., Yang, K.-Y., Peng, C.-K., Sheu, C.-C., Chan, M.-C., Feng, J.-Y., Wang, S.-H., Chen, C.-M., Zheng, Z.-R., and Liang, S.-J. (2022). Clinical Outcome of Nosocomial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients: A Multicenter Retrospective Observational Study. Sci. Rep., 12. · DOI
  12. Peleg, 2010, Hospital-Acquired Infections Due to Gram-Negative Bacteria, N. Engl. J. Med., 362, 1804, 10.1056/NEJMra0904124 · DOI · Paper page
  13. Temkin, 2019, Zero or More: Methodological Challenges of Counting and Estimating Deaths Related to Antibiotic-Resistant Infections, Clin. Infect. Dis., 69, 2029, 10.1093/cid/ciz414 · DOI
  14. Cassini, 2019, Attributable Deaths and Disability-Adjusted Life-Years Caused by Infections with Antibiotic-Resistant Bacteria in the EU and the European Economic Area in 2015: A Population-Level Modelling Analysis, Lancet Infect. Dis., 19, 56, 10.1016/S1473-3099(18)30605-4 · DOI · Paper page
  15. Czaplewski, 2016, Alternatives to Antibiotics-a Pipeline Portfolio Review, Lancet Infect. Dis., 16, 239, 10.1016/S1473-3099(15)00466-1 · DOI · Paper page
  16. Magana, 2020, The Value of Antimicrobial Peptides in the Age of Resistance, Lancet Infect. Dis., 20, e216, 10.1016/S1473-3099(20)30327-3 · DOI · Paper page
  17. Ryu, 2021, Rediscovery of Antimicrobial Peptides as Therapeutic Agents, J. Microbiol., 59, 113, 10.1007/s12275-021-0649-z · DOI
  18. Hassan, M., Flanagan, T.W., Kharouf, N., Bertsch, C., Mancino, D., and Haikel, Y. (2023). Antimicrobial Proteins: Structure, Molecular Action, and Therapeutic Potential. Pharmaceutics, 15. · DOI
  19. Pirtskhalava, 2021, DBAASP v3: Database of Antimicrobial/Cytotoxic Activity and Structure of Peptides as a Resource for Development of New Therapeutics, Nucleic Acids Res., 49, D288, 10.1093/nar/gkaa991 · DOI · Paper page
  20. Mookherjee, 2020, Antimicrobial Host Defence Peptides: Functions and Clinical Potential, Nat. Rev. Drug Discov., 19, 311, 10.1038/s41573-019-0058-8 · DOI · Paper page
  21. Ahmed, A., Siman-Tov, G., Hall, G., Bhalla, N., and Narayanan, A. (2019). Human Antimicrobial Peptides as Therapeutics for Viral Infections. Viruses, 11. · DOI · Paper page
  22. Hancock, 2016, The Immunology of Host Defence Peptides: Beyond Antimicrobial Activity, Nat. Rev. Immunol., 16, 321, 10.1038/nri.2016.29 · DOI · Paper page
  23. Mahlapuu, M., Håkansson, J., Ringstad, L., and Björn, C. (2016). Antimicrobial Peptides: An Emerging Category of Therapeutic Agents. Front. Cell. Infect. Microbiol., 6. · DOI · Paper page
  24. Silva, 2017, Antimicrobial Peptides: Role in Human Disease and Potential as Immunotherapies, Pharmacol. Ther., 178, 132, 10.1016/j.pharmthera.2017.04.002 · DOI
  25. Raffatellu, 2018, Learning from Bacterial Competition in the Host to Develop Antimicrobials, Nat. Med., 24, 1097, 10.1038/s41591-018-0145-0 · DOI
  26. Satyanarayana, T., Johri, B.N., and Das, S.K. (2019). Microbiome: A Source of Novel Bioactive Compounds and Antimicrobial Peptides. Microbial Diversity in Ecosystem Sustainability and Biotechnological Applications: Volume 1. Microbial Diversity in Normal & Extreme Environments, Springer. · DOI
  27. Travkova, 2017, The Interaction of Antimicrobial Peptides with Membranes, Adv. Colloid. Interface Sci., 247, 521, 10.1016/j.cis.2017.06.001 · DOI · Paper page
  28. Kumar, P., Kizhakkedathu, J.N., and Straus, S.K. (2018). Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo. Biomolecules, 8. · DOI · Paper page
  29. Ahmed, T.A.E., and Hammami, R. (2019). Recent Insights into Structure–Function Relationships of Antimicrobial Peptides. J. Food Biochem., 43. · DOI
  30. Abraham, 1987, Extension of the Fragment Method to Calculate Amino Acid Zwitterion and Side Chain Partition Coefficients, Proteins Struct. Funct. Bioinform., 2, 130, 10.1002/prot.340020207 · DOI · Paper page
  31. Andersson, 2016, Mechanisms and Consequences of Bacterial Resistance to Antimicrobial Peptides, Drug Resist. Updates, 26, 43, 10.1016/j.drup.2016.04.002 · DOI · Paper page
  32. Martins, 2018, Antibiotic-Resistant Bacteria Show Widespread Collateral Sensitivity to Antimicrobial Peptides, Nat. Microbiol., 3, 718, 10.1038/s41564-018-0164-0 · DOI · Paper page
  33. Spohn, 2019, Integrated Evolutionary Analysis Reveals Antimicrobial Peptides with Limited Resistance, Nat. Commun., 10, 4538, 10.1038/s41467-019-12364-6 · DOI · Paper page
  34. Le, 2017, Intracellular Targeting Mechanisms by Antimicrobial Peptides, Antimicrob. Agents Chemother., 61, e02340-16, 10.1128/AAC.02340-16 · DOI · Paper page
  35. Scocchi, 2016, Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria, Curr. Top. Med. Chem., 16, 76, 10.2174/1568026615666150703121009 · DOI · Paper page
  36. Matsuzaki, K. (2019). Clinical Application of AMPs. Antimicrobial Peptides: Basics for Clinical Application, Springer. Advances in Experimental Medicine and Biology. · doi:10.1007/978-981-13-3588-4
  37. Mahlapuu, 2020, Antimicrobial Peptides as Therapeutic Agents: Opportunities and Challenges, Crit. Rev. Biotechnol., 40, 978, 10.1080/07388551.2020.1796576 · DOI · Paper page
  38. Wang, 2019, Antimicrobial Peptides: Promising Alternatives in the Post Feeding Antibiotic Era, Med. Res. Rev., 39, 831, 10.1002/med.21542 · DOI · Paper page
  39. Li, B., Yang, N., Wang, X., Hao, Y., Mao, R., Li, Z., Wang, Z., Teng, D., and Wang, J. (2020). An Enhanced Variant Designed from DLP4 Cationic Peptide Against Staphylococcus Aureus CVCC 546. Front. Microbiol., 11. · DOI
  40. Hwang, 1998, Structure–Function Relationships of Antimicrobial Peptides, Biochem. Cell Biol., 76, 235, 10.1139/o98-026 · doi:10.1139/o98-026 · Paper page
  41. Li, 2021, The structure-mechanism relationship and mode of actions of antimicrobial peptides: A review, Trends Food Sci. Technol., 109, 103, 10.1016/j.tifs.2021.01.005 · DOI · Paper page
  42. Tan, 2021, Design, Optimization, and Nanotechnology of Antimicrobial Peptides: From Exploration to Applications, Nano Today, 39, 101229, 10.1016/j.nantod.2021.101229 · DOI · Paper page
  43. Wang, 2016, APD3: The Antimicrobial Peptide Database as a Tool for Research and Education, Nucleic Acids Res., 44, D1087, 10.1093/nar/gkv1278 · DOI · Paper page
  44. Burdukiewicz, M., Sidorczuk, K., Rafacz, D., Pietluch, F., Chilimoniuk, J., Rödiger, S., and Gagat, P. (2020). Proteomic Screening for Prediction and Design of Antimicrobial Peptides with AmpGram. Int. J. Mol. Sci., 21. · DOI
  45. Sidorczuk, K., Gagat, P., Pietluch, F., Kała, J., Rafacz, D., Bąkała, L., Słowik, J., Kolenda, R., Rödiger, S., and Fingerhut, L.C. (2022). Benchmarks in Antimicrobial Peptide Prediction Are Biased Due to the Selection of Negative Data. Brief. Bioinform., 23. · DOI
  46. Pan, 2020, Macrel: Antimicrobial Peptide Screening in Genomes and Metagenomes, PeerJ, 8, e10555, 10.7717/peerj.10555 · DOI
  47. Fingerhut, 2021, Ampir: An R Package for Fast Genome-Wide Prediction of Antimicrobial Peptides, Bioinformatics, 36, 5262, 10.1093/bioinformatics/btaa653 · DOI
  48. Veltri, 2018, Deep Learning Improves Antimicrobial Peptide Recognition, Bioinformatics, 34, 2740, 10.1093/bioinformatics/bty179 · DOI · Paper page
  49. Lawrence, 2021, amPEPpy 1.0: A Portable and Accurate Antimicrobial Peptide Prediction Tool, Bioinformatics, 37, 2058, 10.1093/bioinformatics/btaa917 · DOI
  50. Gautier, 2008, HELIQUEST: A Web Server to Screen Sequences with Specific α-Helical Properties, Bioinformatics, 24, 2101, 10.1093/bioinformatics/btn392 · DOI · Paper page
  51. Zhou, 2022, I-TASSER-MTD: A Deep-Learning-Based Platform for Multi-Domain Protein Structure and Function Prediction, Nat. Protoc., 17, 2326, 10.1038/s41596-022-00728-0 · DOI · Paper page
  52. Lamiable, 2016, PEP-FOLD3: Faster de Novo Structure Prediction for Linear Peptides in Solution and in Complex, Nucleic Acids Res., 44, W449, 10.1093/nar/gkw329 · DOI · Paper page
  53. Jones, 1999, Protein Secondary Structure Prediction Based on Position-Specific Scoring Matrices 1 1Edited by G. Von Heijne, J. Mol. Biol., 292, 195, 10.1006/jmbi.1999.3091 · DOI · Paper page
  54. Valle, 2024, PyAMPA: A High-Throughput Prediction and Optimization Tool for Antimicrobial Peptides, mSystems, 9, e01358-23, 10.1128/msystems.01358-23 · DOI
  55. Bessalle, 1992, Augmentation of the Antibacterial Activity of Magainin by Positive-Charge Chain Extension, Antimicrob. Agents Chemother., 36, 313, 10.1128/AAC.36.2.313 · doi:10.1128/aac.36.2.313
  56. Higgs, 2007, Modification of Chicken Avian β-Defensin-8 at Positively Selected Amino Acid Sites Enhances Specific Antimicrobial Activity, Immunogenetics, 59, 573, 10.1007/s00251-007-0219-5 · DOI
  57. Jiang, 2008, Effects of Net Charge and the Number of Positively Charged Residues on the Biological Activity of Amphipathic A-helical Cationic Antimicrobial Peptides, Biopolymers, 90, 369, 10.1002/bip.20911 · DOI · Paper page
  58. Yount, 2006, Advances in Antimicrobial Peptide Immunobiology, Biopolymers, 84, 435, 10.1002/bip.20543 · DOI · Paper page
  59. Frederiksen, 2020, Alternating Cationic-Hydrophobic Peptide/Peptoid Hybrids: Influence of Hydrophobicity on Antibacterial Activity and Cell Selectivity, ChemMedChem, 15, 2544, 10.1002/cmdc.202000526 · doi:10.1002/cmdc.202000526
  60. Shang, 2016, The Effects of LPS on the Activity of Trp-Containing Antimicrobial Peptides against Gram-Negative Bacteria and Endotoxin Neutralization, Acta Biomater., 33, 153, 10.1016/j.actbio.2016.01.019 · DOI
  61. Yount, 2005, Immunocontinuum: Perspectives in Antimicrobial Peptide Mechanisms of Action and Resistance, Protein Pept. Lett., 12, 49, 10.2174/0929866053405959 · DOI
  62. Dennison, 2005, Are Oblique Orientated α-Helices Used by Antimicrobial Peptides for Membrane Invasion?, Protein Pept. Lett., 12, 27, 10.2174/0929866053406039 · DOI
  63. Glukhov, 2005, Basis for Selectivity of Cationic Antimicrobial Peptides for Bacterial Versus Mammalian Membranes, J. Biol. Chem., 280, 33960, 10.1074/jbc.M507042200 · DOI · Paper page
  64. Haney, 2007, Solution Structures and Model Membrane Interactions of Lactoferrampin, an Antimicrobial Peptide Derived from Bovine Lactoferrin, Biochim. Biophys. Acta (BBA) Biomembr., 1768, 2355, 10.1016/j.bbamem.2007.04.018 · DOI
  65. Sparks, 2014, Comparisons of Interfacial Phe, Tyr, and Trp Residues as Determinants of Orientation and Dynamics for GWALP Transmembrane Peptides, Biochemistry, 53, 3637, 10.1021/bi500439x · DOI
  66. Shahmiri, M., Cornell, B., and Mechler, A. (2017). Phenylalanine Residues Act as Membrane Anchors in the Antimicrobial Action of Aurein 1.2. Biointerphases, 12. · doi:10.1116/1.4995674
  67. Lander, 2023, Roles of Inter- and Intramolecular Tryptophan Interactions in Membrane-Active Proteins Revealed by Racemic Protein Crystallography, Commun. Chem., 6, 154, 10.1038/s42004-023-00953-y · DOI
  68. Schmidtchen, 2009, Boosting Antimicrobial Peptides by Hydrophobic Oligopeptide End Tags, J. Biol. Chem., 284, 17584, 10.1074/jbc.M109.011650 · DOI
  69. Schmidtchen, 2011, Membrane Selectivity by W-Tagging of Antimicrobial Peptides, Biochim. Biophys. Acta (BBA) Biomembr., 1808, 1081, 10.1016/j.bbamem.2010.12.020 · DOI
  70. Malmsten, M., Kasetty, G., Pasupuleti, M., Alenfall, J., and Schmidtchen, A. (2011). Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP. PLoS ONE, 6. · DOI
  71. Molhoek, 2010, Chicken Cathelicidin-2-Derived Peptides with Enhanced Immunomodulatory and Antibacterial Activities against Biological Warfare Agents, Int. J. Antimicrob. Agents, 36, 271, 10.1016/j.ijantimicag.2010.06.001 · doi:10.1016/j.ijantimicag.2010.06.001
  72. Molhoek, 2009, Identification of Chicken Cathelicidin-2 Core Elements Involved in Antibacterial and Immunomodulatory Activities, Mol. Immunol., 46, 2465, 10.1016/j.molimm.2009.05.019 · DOI
  73. Chen, L., Shen, T., Liu, Y., Zhou, J., Shi, S., Wang, Y., Zhao, Z., Yan, Z., Liao, C., and Wang, C. (2020). Enhancing the Antibacterial Activity of Antimicrobial Peptide PMAP-37(F34-R) by Cholesterol Modification. BMC Vet. Res., 16. · DOI
  74. Zhou, 2019, Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37, J. Pept. Sci., 25, e3220, 10.1002/psc.3220 · doi:10.1002/psc.3220
  75. Liu, 2020, Effect of N-Methylated and Fatty Acid Conjugation on Analogs of Antimicrobial Peptide Anoplin, Eur. J. Pharm. Sci., 152, 105453, 10.1016/j.ejps.2020.105453 · DOI
  76. Zhong, 2020, Antimicrobial Peptides Conjugated with Fatty Acids on the Side Chain of D-Amino Acid Promises Antimicrobial Potency against Multidrug-Resistant Bacteria, Eur. J. Pharm. Sci., 141, 105123, 10.1016/j.ejps.2019.105123 · DOI
  77. Liu, 2021, Fatty Acid Modified-Antimicrobial Peptide Analogues with Potent Antimicrobial Activity and Topical Therapeutic Efficacy against Staphylococcus Hyicus, Appl. Microbiol. Biotechnol., 105, 5845, 10.1007/s00253-021-11454-0 · doi:10.1007/s00253-021-11454-0
  78. Chatterjee, 2013, N-Methylation of Peptides and Proteins: An Important Element for Modulating Biological Functions, Angew. Chem. Int. Ed., 52, 254, 10.1002/anie.201205674 · DOI · Paper page
  79. Smirnova, 2020, Indolicidin Analogs with Broad-Spectrum Antimicrobial Activity and Low Hemolytic Activity, Peptides, 132, 170356, 10.1016/j.peptides.2020.170356 · DOI
  80. Yeaman, 2003, Mechanisms of Antimicrobial Peptide Action and Resistance, Pharmacol. Rev., 55, 27, 10.1124/pr.55.1.2 · DOI · Paper page
  81. Dathe, 1999, Structural Features of Helical Antimicrobial Peptides: Their Potential to Modulate Activity on Model Membranes and Biological Cells, Biochim. Biophys. Acta (BBA) Biomembr., 1462, 71, 10.1016/S0005-2736(99)00201-1 · DOI · Paper page
  82. Dempsey, 1990, The Actions of Melittin on Membranes, Biochim. Biophys. Acta (BBA) Rev. Biomembr., 1031, 143, 10.1016/0304-4157(90)90006-X · DOI · Paper page
  83. Asthana, 2004, Dissection of Antibacterial and Toxic Activity of Melittin, J. Biol. Chem., 279, 55042, 10.1074/jbc.M408881200 · DOI · Paper page
  84. Chen, 2005, Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index, J. Biol. Chem., 280, 12316, 10.1074/jbc.M413406200 · DOI · Paper page
  85. Hawrani, 2008, Origin of Low Mammalian Cell Toxicity in a Class of Highly Active Antimicrobial Amphipathic Helical Peptides, J. Biol. Chem., 283, 18636, 10.1074/jbc.M709154200 · DOI
  86. Zhang, S.-K., Song, J., Gong, F., Li, S.-B., Chang, H.-Y., Xie, H.-M., Gao, H.-W., Tan, Y.-X., and Ji, S.-P. (2016). Design of an α-Helical Antimicrobial Peptide with Improved Cell-Selective and Potent Anti-Biofilm Activity. Sci. Rep., 6. · DOI · Paper page
  87. Srivastava, 2016, Modulation of Anti-Endotoxin Property of Temporin L by Minor Amino Acid Substitution in Identified Phenylalanine Zipper Sequence, Biochem. J., 473, 4045, 10.1042/BCJ20160713 · DOI
  88. Song, 2019, Therapeutic Potential of Trp-Rich Engineered Amphiphiles by Single Hydrophobic Amino Acid End-Tagging, ACS Appl. Mater. Interfaces, 11, 43820, 10.1021/acsami.9b12706 · doi:10.1021/acsami.9b12706
  89. Li, 2013, Dissociation of Antimicrobial and Hemolytic Activities of Gramicidin S through N–Methylation Modification, ChemMedChem, 8, 1865, 10.1002/cmdc.201300232 · doi:10.1002/cmdc.201300232
  90. He, 2017, Design, Crystal Structure and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides against Multidrug Resistant Pseudomonas Aeruginosa, Chem. Sci., 8, 7464, 10.1039/C7SC01599B · DOI
  91. Mani, 2006, Membrane-Bound Dimer Structure of a β-Hairpin Antimicrobial Peptide from Rotational-Echo Double-Resonance Solid-State NMR, Biochemistry, 45, 8341, 10.1021/bi060305b · doi:10.1021/bi060305b
  92. Harwig, 1996, Intramolecular Disulfide Bonds Enhance the Antimicrobial and Lytic Activities of Protegrins at Physiological Sodium Chloride Concentrations, Eur. J. Biochem., 240, 352, 10.1111/j.1432-1033.1996.0352h.x · DOI
  93. Kokryakov, 1993, Protegrins: Leukocyte Antimicrobial Peptides That Combine Features of Corticostatic Defensins and Tachyplesins, FEBS Lett., 327, 231, 10.1016/0014-5793(93)80175-T · DOI · Paper page
  94. Tam, 2000, Membranolytic Selectivity of Cystine-stabilized Cyclic Protegrins, Eur. J. Biochem., 267, 3289, 10.1046/j.1432-1327.2000.01359.x · DOI
  95. Wiradharma, 2011, Synthetic Cationic Amphiphilic α-Helical Peptides as Antimicrobial Agents, Biomaterials, 32, 2204, 10.1016/j.biomaterials.2010.11.054 · DOI · Paper page
  96. Hu, 2011, Designed Antimicrobial and Antitumor Peptides with High Selectivity, Biomacromolecules, 12, 3839, 10.1021/bm201098j · DOI
  97. Chen, 2014, High Cell Selectivity and Low-Level Antibacterial Resistance of Designed Amphiphilic Peptide G(IIKK)3I-NH2, ACS Appl. Mater. Interfaces, 6, 16529, 10.1021/am504973d · DOI
  98. Ahmad, 2009, Structure–Function Study of Cathelicidin-Derived Bovine Antimicrobial Peptide BMAP-28: Design of Its Cell-Selective Analogs by Amino Acid Substitutions in the Heptad Repeat Sequences, Biochim. Biophys. Acta (BBA) Biomembr., 1788, 2411, 10.1016/j.bbamem.2009.08.021 · DOI
  99. Ahmad, 2009, Design of Nontoxic Analogues of Cathelicidin-Derived Bovine Antimicrobial Peptide BMAP-27: The Role of Leucine as Well as Phenylalanine Zipper Sequences in Determining Its Toxicity, Biochemistry, 48, 10905, 10.1021/bi9009874 · DOI
  100. Kumar, 2016, Single Amino Acid Substitutions at Specific Positions of the Heptad Repeat Sequence of Piscidin-1 Yielded Novel Analogs That Show Low Cytotoxicity and In Vitro and In Vivo Antiendotoxin Activity, Antimicrob. Agents Chemother., 60, 3687, 10.1128/AAC.02341-15 · DOI
  101. Cohen, 1990, α-Helical Coiled Coils and Bundles: How to Design an A-helical Protein, Proteins, 7, 1, 10.1002/prot.340070102 · DOI · Paper page
  102. Jelesarov, 1998, Salt Effects on Hydrophobic Interaction and Charge Screening in the Folding of a Negatively Charged Peptide to a Coiled Coil (Leucine Zipper), Biochemistry, 37, 7539, 10.1021/bi972977v · DOI
  103. Dou, 2017, Novel Design of Heptad Amphiphiles To Enhance Cell Selectivity, Salt Resistance, Antibiofilm Properties and Their Membrane-Disruptive Mechanism, J. Med. Chem., 60, 2257, 10.1021/acs.jmedchem.6b01457 · doi:10.1021/acs.jmedchem.6b01457
  104. Edwards, 2016, Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides, ACS Infect. Dis., 2, 442, 10.1021/acsinfecdis.6b00045 · DOI · Paper page
  105. Shao, 2021, Cross-Strand Interaction, Central Bending, and Sequence Pattern Act as Biomodulators of Simplified β-Hairpin Antimicrobial Amphiphiles, Small, 17, 2003899, 10.1002/smll.202003899 · DOI
  106. Cardoso, M.H., Orozco, R.Q., Rezende, S.B., Rodrigues, G., Oshiro, K.G.N., Cândido, E.S., and Franco, O.L. (2020). Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates?. Front. Microbiol., 10. · DOI · Paper page
  107. Agüero-Chapin, G., Galpert-Cañizares, D., Domínguez-Pérez, D., Marrero-Ponce, Y., Pérez-Machado, G., Teijeira, M., and Antunes, A. (2022). Emerging Computational Approaches for Antimicrobial Peptide Discovery. Antibiotics, 11. · DOI
  108. Zhang, H., Wang, Y., Zhu, Y., Huang, P., Gao, Q., Li, X., Chen, Z., Liu, Y., Jiang, J., and Gao, Y. Machine Learning and Genetic Algorithm-Guided Directed Evolution for the Development of Antimicrobial Peptides. J. Adv. Res., 2024. in press. · DOI
  109. Yoshida, 2018, Using Evolutionary Algorithms and Machine Learning to Explore Sequence Space for the Discovery of Antimicrobial Peptides, Chem, 4, 533, 10.1016/j.chempr.2018.01.005 · DOI · Paper page
  110. Maccari, G., Luca, M.D., Nifosí, R., Cardarelli, F., Signore, G., Boccardi, C., and Bifone, A. (2013). Antimicrobial Peptides Design by Evolutionary Multiobjective Optimization. PLoS Comput. Biol., 9. · DOI
  111. Xu, J., Li, F., Leier, A., Xiang, D., Shen, H.-H., Marquez Lago, T.T., Li, J., Yu, D.-J., and Song, J. (2021). Comprehensive Assessment of Machine Learning-Based Methods for Predicting Antimicrobial Peptides. Brief. Bioinform., 22. · DOI
  112. Walls, D., and Loughran, S.T. (2017). Antimicrobial Peptide Production and Purification. Protein Chromatography: Methods and Protocols, Springer.
  113. Gaglione, 2019, Cost-Effective Production of Recombinant Peptides in Escherichia coli, New Biotechnol., 51, 39, 10.1016/j.nbt.2019.02.004 · DOI
  114. Tiwari, P., Srivastava, Y., Sharma, A., and Vinayagam, R. (2023). Antimicrobial Peptides: The Production of Novel Peptide-Based Therapeutics in Plant Systems. Life, 13. · DOI
  115. Papo, 2002, The Consequence of Sequence Alteration of an Amphipathic α-Helical Antimicrobial Peptide and Its Diastereomers, J. Biol. Chem., 277, 33913, 10.1074/jbc.M204928200 · DOI · Paper page
  116. Li, Y., Liu, T., Liu, Y., Tan, Z., Ju, Y., Yang, Y., and Dong, W. (2019). Antimicrobial Activity, Membrane Interaction and Stability of the D-Amino Acid Substituted Analogs of Antimicrobial Peptide W3R6. J. Photochem. Photobiol. B Biol., 200. · doi:10.1016/j.jphotobiol.2019.111645
  117. Zai, Y., Ying, Y., Ye, Z., Zhou, M., Ma, C., Shi, Z., Chen, X., Xi, X., Chen, T., and Wang, L. (2020). Broad-Spectrum Antimicrobial Activity and Improved Stability of a D-Amino Acid Enantiomer of DMPC-10A, the Designed Derivative of Dermaseptin Truncates. Antibiotics, 9. · doi:10.3390/antibiotics9090627
  118. Gentilucci, 2010, Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization, Curr. Pharm. Des., 16, 3185, 10.2174/138161210793292555 · DOI · Paper page
  119. Rozek, 2003, Structure-Based Design of an Indolicidin Peptide Analogue with Increased Protease Stability, Biochemistry, 42, 14130, 10.1021/bi035643g · DOI · Paper page
  120. Pham, 2013, Truncated and Constrained Helical Analogs of Antimicrobial Esculentin-2EM, Bioorganic Med. Chem. Lett., 23, 6717, 10.1016/j.bmcl.2013.10.031 · DOI
  121. Li, 2020, Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides, J. Med. Chem., 63, 4081, 10.1021/acs.jmedchem.9b02025 · DOI
  122. Park, 2004, Helix Stability Confers Salt Resistance upon Helical Antimicrobial Peptides *, J. Biol. Chem., 279, 13896, 10.1074/jbc.M311418200 · DOI
  123. Yu, 2011, Easy Strategy To Increase Salt Resistance of Antimicrobial Peptides, Antimicrob. Agents Chemother., 55, 4918, 10.1128/AAC.00202-11 · DOI
  124. Hayes, 2021, Approaches for Peptide and Protein Cyclisation, Org. Biomol. Chem., 19, 3983, 10.1039/D1OB00411E · DOI
  125. Ye, 2018, Self-Assembly Dynamics and Antimicrobial Activity of All L- and D-Amino Acid Enantiomers of a Designer Peptide, Nanoscale, 11, 266, 10.1039/C8NR07334A · DOI
  126. Wang, 2023, Unnatural Amino Acids: Promising Implications for the Development of New Antimicrobial Peptides, Crit. Rev. Microbiol., 49, 231, 10.1080/1040841X.2022.2047008 · DOI
  127. Zhu, 2022, Antimicrobial Peptides, Conventional Antibiotics, and Their Synergistic Utility for the Treatment of Drug-Resistant Infections, Med. Res. Rev., 42, 1377, 10.1002/med.21879 · DOI · Paper page
  128. Kim, 2017, LL-37-Derived Short Antimicrobial Peptide KR-12-A5 and Its d-Amino Acid Substituted Analogs with Cell Selectivity, Anti-Biofilm Activity, Synergistic Effect with Conventional Antibiotics, and Anti-Inflammatory Activity, Eur. J. Med. Chem., 136, 428, 10.1016/j.ejmech.2017.05.028 · DOI
  129. Reffuveille, 2014, A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms, Antimicrob. Agents Chemother., 58, 5363, 10.1128/AAC.03163-14 · DOI · Paper page
  130. Song, 2020, A Broad-Spectrum Antibiotic Adjuvant Reverses Multidrug-Resistant Gram-Negative Pathogens, Nat. Microbiol., 5, 1040, 10.1038/s41564-020-0723-z · DOI · Paper page
  131. Zhang, 2021, Antimicrobial Peptides: Mechanism of Action, Activity and Clinical Potential, Mil. Med. Res., 8, 48
  132. Tripathi, A.K., Kumari, T., Harioudh, M.K., Yadav, P.K., Kathuria, M., Shukla, P.K., Mitra, K., and Ghosh, J.K. (2017). Identification of GXXXXG Motif in Chrysophsin-1 and Its Implication in the Design of Analogs with Cell-Selective Antimicrobial and Anti-Endotoxin Activities. Sci. Rep., 7. · DOI
  133. Tripathi, 2017, Selective Phenylalanine to Proline Substitution for Improved Antimicrobial and Anticancer Activities of Peptides Designed on Phenylalanine Heptad Repeat, Acta Biomater., 57, 170, 10.1016/j.actbio.2017.05.007 · DOI
  134. Porto, 2018, Joker: An Algorithm to Insert Patterns into Sequences for Designing Antimicrobial Peptides, Biochim. Biophys. Acta (BBA) Gen. Subj., 1862, 2043, 10.1016/j.bbagen.2018.06.011 · DOI
  135. Porto, 2018, In Silico Optimization of a Guava Antimicrobial Peptide Enables Combinatorial Exploration for Peptide Design, Nat. Commun., 9, 1490, 10.1038/s41467-018-03746-3 · DOI · Paper page

Metadata

Authors
Gagat, P., Ostrówka, M., Duda-Madej, A., & Mackiewicz, P.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2024-10-09
Volume
25
Issue
19
Pages
10821
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4403253158
Cited by
163
References
4
FWCI
35.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure. https://app.cochat.ai/papers/10.3390/ijms251910821
The paper
Gagat, P., Ostrówka, M., Duda-Madej, A., & Mackiewicz, P. (2024). Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910821

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.